Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium
- PMID: 6234599
- PMCID: PMC345390
- DOI: 10.1073/pnas.81.13.4169
Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium
Abstract
The human T-cell leukemia, Jurkat, and a T3-negative mutant of Jurkat (S.5) were used to study the role of T3 in human T-cell activation. Incubation of Jurkat with phytohemagglutinin (PHA) resulted in the production of interleukin 2, which was markedly increased by the addition of phorbol 12-myristate 13-acetate (PMA). Antibodies reactive with T3 could activate Jurkat only if added together with PMA. However, S.5 cells failed to produce interleukin 2 in response to PHA and produced 1/16th the interleukin 2 activity that Jurkat produced in response to PHA and PMA. Incubation of S.5 cells with the calcium ionophore A23187 and PMA resulted in the production of interleukin 2 activity comparable to that produced by Jurkat. Like antibodies reactive with T3, A23187 demonstrated an obligate requirement for PMA in order to activate Jurkat or S.5. These observations suggested that T3 might participate in T-cell activation through mechanisms that increase intracellular Ca2+. This was examined by using the Ca2+ sensitive fluor, quin-2, to measure levels of cytoplasmic free Ca2+ [( Ca2+]i). Addition of PHA, A23187, or monoclonal antibodies reactive with T3 to Jurkat cells resulted in substantial increases of [Ca2+]i. In contrast, only A23187 could induce an increase in [Ca2+]i in S.5 cells. Three other monoclonal antibodies reactive with other membrane antigens expressed on Jurkat or S.5 did not increase [Ca2+]i. These results suggest that T3 and/or associated molecules participate in T-cell activation through mechanisms that lead to increases in [Ca2+]i and that their expression is a relative requirement for T-cell activation by PHA.
Similar articles
-
Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation.Proc Natl Acad Sci U S A. 1987 Mar;84(6):1654-8. doi: 10.1073/pnas.84.6.1654. Proc Natl Acad Sci U S A. 1987. PMID: 2951735 Free PMC article.
-
Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells.J Immunol. 1986 Aug 1;137(3):819-25. J Immunol. 1986. PMID: 3088111
-
Activation of IL 1-dependent and IL 1-independent T cell lines by calcium ionophore and phorbol ester.J Immunol. 1986 Feb 1;136(3):1033-7. J Immunol. 1986. PMID: 3079793
-
Chymotryptic-type protease inhibitors block the increase in Ca2+ and Il-2 production in activated Jurkat T cells.J Immunol. 1989 Feb 15;142(4):1253-9. J Immunol. 1989. PMID: 2521661
-
Analysis of isolated and combined effects of calcium ionophore and phorbol ester on T lymphocyte activation.Clin Exp Immunol. 1986 Sep;65(3):559-69. Clin Exp Immunol. 1986. PMID: 3096619 Free PMC article.
Cited by
-
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.J Exp Med. 1991 Apr 1;173(4):869-79. doi: 10.1084/jem.173.4.869. J Exp Med. 1991. PMID: 1672545 Free PMC article.
-
Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.Proc Natl Acad Sci U S A. 1989 Jul;86(13):5069-73. doi: 10.1073/pnas.86.13.5069. Proc Natl Acad Sci U S A. 1989. PMID: 2787027 Free PMC article.
-
Mitogen-induced oscillations of cytosolic Ca2+ and transmembrane Ca2+ current in human leukemic T cells.Cell Regul. 1989 Nov;1(1):99-112. doi: 10.1091/mbc.1.1.99. Cell Regul. 1989. PMID: 2519622 Free PMC article.
-
Slow phosphorylation of a tyrosine residue in LAT optimizes T cell ligand discrimination.Nat Immunol. 2019 Nov;20(11):1481-1493. doi: 10.1038/s41590-019-0502-2. Epub 2019 Oct 14. Nat Immunol. 2019. PMID: 31611699 Free PMC article.
-
The use of the clinical immunology laboratory.Clin Rev Allergy. 1994 Summer;12(2):125-49. doi: 10.1007/BF02802351. Clin Rev Allergy. 1994. PMID: 7954186 Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous